✦ LIBER ✦

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) study

✍ Scribed by S.E. Kjeldsen; B. Dahlor; R.B. Devereux

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The interaction between aspirin and losa

✍ Eigil Fossum; Sverre E. Kjeldsen; Björn Dahlöf; Richard B. Devereux; Stevo Juliu 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 74 KB

Body Build and Risk of Cardiovascular Ev

✍ G. de Simone; K. Wachtell; V. Palmieri 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Cost-effectiveness of losartan-based the

✍ McInnes, G; Burke, T A; Carides, G 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Cardiovascular morbidity and mortality i

✍ Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beever 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 124 KB

Cardiovascular morbidity and mortality i

✍ L.H. Lindholm; H. Ibsen; B. Dahof 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Cardiovascular morbidity and mortality i

✍ Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; U 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 110 KB